Adolescents receive a weight-based dose equivalent to the 50 mg adult dose Adolescents 12-17 years old who complete participation in the pharmacokinetic (PK) run-in study will be eligible to screen in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback